FDA approves a new monoclonal antibody for Covid-19 that works against the Omicron variant
The US Food and Drug Administration has approved a new monoclonal antibody treatment for Covid-19 that appears to act against the virus’s Omicron form. Monoclonal antibodies are lab-created proteins that mimic the immune system’s ability to fight diseases such as the coronavirus. Eli Lilly and Company’s Bebtelovimab is a monoclonal antibody administered via intravenous injection.…